CD1D and breast cancer: The target cells consisted of two breast cancer cellular lines, MDA-MB468 and SK-BR3, which were analyzed in terms of differential target molecule (EGFR) expression, as well as the presence of non-specific (MICA/B) and specific (CD1d) activating and inhibitory molecules (Fas).